Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Carrum Health Appoints Randy K. Hawkins, M.D. as Chief Medical Officer
Carrum Health, the first value-based Centers of Excellence (COEs) platform for surgical care, today announced Randy […]
Sandata Announces Emmet O'Gara as New Chief Executive Officer
Sandata is pleased to announce the appointment of Emmet O’Gara as the organization’s next Chief Executive Officer. […]
Genoskin Appoints Dr Nicolas Gaudenzio as Chief Scientific Officer
Genoskin, a biotechnology company that provides transformative platforms and tools leveraging live ex vivo human skin to […]
Chemomab Therapeutics Names Donald R. Marvin Chief Financial Officer, Executive Vice President and Chief Operating Officer
Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab) a clinical-stage biotech company focused on the discovery and development […]
Bayer Announces Christoph Koenen as New Global Head of Clinical Development and Operations within Pharmaceuticals Research and Development at Bayer
Bayer today announced Christoph Koenen as the new Global Head of Clinical Development and Operations […]
Provention Bio Announces Appointment of Thierry Chauche as Chief Financial Officer
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today […]
WELL Health Adds Chief Medical Officer Sean Kelly to Leadership Team
Well Health Inc., a SaaS digital health leader in patient communications and 2021 Best in KLAS […]
Mogrify Appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor
Mogrify Limited (Mogrify®), a biopharmaceutical company pioneering the development of a new class of in […]
Muna Therapeutics Appoints Dr. Niels Plath as Chief Scientific Officer
Muna Therapeutics (“Muna“), pioneering the development of novel, first-in-class small molecule therapeutics for neurodegenerative diseases, […]
Amphista Therapeutics Appoints CBO, Beverley Carr
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more